MicroRNA1 therapies

Details MicroRNA1 therapies MicroRNA1 therapies

2008-06-24

2008-06-24

Vivlemore, Tracy (Department: 1635)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C536S024500, C435S455000

Reexamination Certificate

active

07390792

ABSTRACT:
Delta protein expression in a cell is reduced by introducing miR-1 into the cell, and detecting a resultant reduction of Delta protein expression in the cell.

REFERENCES:
patent: 2005/0059005 (2005-03-01), Tuschi et al.
Patel et al. Cancer Research 2005, vol. 65, pp. 8690-8697.
Purow et al. Cancer Research 2005, vol. 65, pp. 2353-2363.
Opalinska et al. Nature Reviews Drug Discovery, 2002, vol. 1, p. 503-514.
Brennecke et al. Genes & Development 2005, vol. 19, pp. 2261-2264.
Zhao et al. Nature 2005, vol. 436, pp. 214-220.
Opalinska et al. Nature Reviews Drug Discovery, 2002, vol. 1, p. 503-514.

Affiliated with

Also associated with

Rating

MicroRNA1 therapies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with MicroRNA1 therapies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and MicroRNA1 therapies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2803294